Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
Aprea Therapeutics (APRE) Stock Price & Analysis
394 Followers
APRE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.33 - $25.80
Previous Close$3.4
Volume13.83K
Average Volume (3M)12.48K
Market Cap
$12.69M
Enterprise Value-$18.31M
Total Cash (Recent Filing)$31.00M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.5
Beta1.01
Next Earnings
Aug 10, 2023EPS Estimate
-$1.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.71
Shares Outstanding3,731,571
10 Day Avg. Volume11,568
30 Day Avg. Volume12,480
Standard Deviation3.13
R-Squared0.00224
Alpha0.39
Financial Highlights & Ratios
Price to Book (P/B)-1.01
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.54
Forecast
1Y Price Target
$18.00Price Target Upside429.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Aprea Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
APRE FAQ
What was Aprea Therapeutics Inc’s price range in the past 12 months?
Aprea Therapeutics Inc lowest stock price was $3.33 and its highest was $25.80 in the past 12 months.
What is Aprea Therapeutics Inc’s market cap?
Currently, no data Available
When is Aprea Therapeutics Inc’s upcoming earnings report date?
Aprea Therapeutics Inc’s upcoming earnings report date is Aug 10, 2023 which is in 74 days.
How were Aprea Therapeutics Inc’s earnings last quarter?
Aprea Therapeutics Inc released its earnings results on May 15, 2023. The company reported -$1.34 earnings per share for the quarter, beating the consensus estimate of -$1.505 by $0.165.
Is Aprea Therapeutics Inc overvalued?
According to Wall Street analysts Aprea Therapeutics Inc’s price is currently Undervalued.
Does Aprea Therapeutics Inc pay dividends?
Aprea Therapeutics Inc does not currently pay dividends.
What is Aprea Therapeutics Inc’s EPS estimate?
Aprea Therapeutics Inc’s EPS estimate is -$1.43.
How many shares outstanding does Aprea Therapeutics Inc have?
Aprea Therapeutics Inc has 3,731,571 shares outstanding.
What happened to Aprea Therapeutics Inc’s price movement after its last earnings report?
Aprea Therapeutics Inc reported an EPS of -$1.34 in its last earnings report, beating expectations of -$1.505. Following the earnings report the stock price went up 6.284%.
Which hedge fund is a major shareholder of Aprea Therapeutics Inc?
Among the largest hedge funds holding Aprea Therapeutics Inc’s share is Blackstone Inc.. It holds Aprea Therapeutics Inc’s shares valued at 5K.
---
Aprea Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.00 (429.41% Upside)
$18.00 (429.41% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-78.88%
12-Months-Change
Fundamentals
Return on Equity
-305.69%
Trailing 12-Months
Asset Growth
-36.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Aprea Therapeutics Inc
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded in 2002 and is headquartered in Boston, MA.
---
Top 5 ETFs holding APRE
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold APRE. The ETFs are listed according to market value of APRE within the ETF
---
Neoleukin Therapeutics
―
AgeX Therapeutics
―
Forte Biosciences
―
Aceragen
―
GeoVax Labs
―
---